Drawing for PAR PATIENT ASSISTANCE RESOURCE

USPTO serial 87535591

PAR PATIENT ASSISTANCE RESOURCE

Reviewed by CopyMark Law Group

Reg. 5439849Status 702Registered
Filing date
Status date
Registration date
Apr 3, 2018
Examiner
LEASER, ANDREW C
Law office
TMO LAW OFFICE 117

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PAR PATIENT ASSISTANCE RESOURCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

Camille M. Miller Cozen O'Connor1650 Market Street, Suite 2800One Liberty PlacePhiladelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
035Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patientACTIVEAug 28, 2017
036Providing health insurance information about health insurance benefits to patients; Financial administration of patient reimbursement programs for pharmaceuticals; Financial administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patientACTIVEAug 28, 2017
044Patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patientACTIVEAug 28, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 2, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 14, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 4, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 16, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 28, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 1, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 7, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 7, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 7, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 5, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Apr 3, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 22, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 3, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 1, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 28, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 27, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 26, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 9, 2018IUAFUSE AMENDMENT FILED—
Feb 9, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 6, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 3, 2017ALIEASSIGNED TO LIE—
Oct 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 23, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 23, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 23, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2017DOCKASSIGNED TO EXAMINER—
Oct 11, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 27, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 26, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 24, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance